Latest Capital Raise News

Eclipse Metals has commenced diamond drilling at its Greenland rare earth project, backed by a $4 million placement to expand and upgrade its resource. The move aligns with strategic plans for a Nasdaq dual listing amid growing global supply chain concerns.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

ActivEX Limited has completed a significant $800,000 share placement to True Creation Limited, aiming to strengthen its financial footing and advance exploration projects.

Biotron Limited is set to acquire Sedarex Limited, gaining global patents for SedRx, a next-generation general anaesthetic, supported by a $2.5 million capital raising to fund regulatory and development milestones.

Bod Science Limited reported a $576,000 net operating cash outflow for the September quarter, sustained by funding from Biortica Agrimed Limited under a Deed of Company Arrangement as it pursues a backdoor listing.

Pinnacle Minerals Limited has had its trading suspension lifted following a significant announcement about an acquisition and capital raise, signaling renewed momentum for the mining explorer.

Kairos Minerals has raised approximately A$27 million through a premium share placement to fund drilling and development at its Mt York and Roe Hills gold projects in Western Australia, attracting robust demand from institutional investors.

CuFe Ltd has raised $5.4 million through a strategic placement to fund exploration and feasibility studies at its Tennant Creek Copper/Gold project, including a focus on critical mineral bismuth.

Aruma Resources has locked in $3.515 million through a placement to fund targeted exploration across its copper, heavy mineral sands, and uranium projects in Australia. The capital raise, supported by directors and new investors, aims to advance drilling and sampling programs at key sites.

Skin Elements Limited has locked in $2.5 million through a two-tranche placement to accelerate the commercial rollout of its SE Formula biotechnology products, offering investors discounted shares and options.

WAM Income Maximiser Limited (WMX) has outperformed its benchmark since its IPO, fully deploying capital ahead of schedule and delivering increasing monthly fully franked dividends.